FN1 and prostate carcinoma: To assess the role of RNase L in regulating integrin β1 expression and activation, prostate cancer cells depleted of RNase L or WT were allowed to spread on FN and cell suspensions were fixed and incubated with integrin β1 antibodies to label cell surface integrin β1.